UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical and molecular characterization of patients with cancer of unknown primary in the modern era

Annals of oncology, 2017-12, Vol.28 (12), p.3015-3021

2017

Volltextzugriff (PDF)

Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)

Journal of surgical oncology, 2008-12, Vol.98 (7), p.485-489

2008

Volltextzugriff (PDF)

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas

British journal of cancer, 2013-08, Vol.109 (4), p.915-919

2013

Volltextzugriff (PDF)

Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer

Annals of oncology, 2009-07, Vol.20 (7), p.1236-1241

2009

Volltextzugriff (PDF)

Tobacco Use Is Associated with Increased Recurrence and Death from Gastric Cancer

Annals of surgical oncology, 2012-07, Vol.19 (7), p.2088-2094

2012

Volltextzugriff (PDF)

Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis

Annals of oncology, 2007-12, Vol.18 (12), p.1995-1999

2007

Volltextzugriff (PDF)

Risk factors for developing a new venous thromboembolism in ambulatory patients with non‐hematologic malignancies and impact on survival for gastroesophageal malignancies

Journal of thrombosis and haemostasis, 2010-08, Vol.8 (8), p.1702-1709

2010

Volltextzugriff (PDF)

A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma

Annals of oncology, 2008-01, Vol.19 (1), p.86-91

2008

Volltextzugriff (PDF)

Pancreatic adenocarcinoma in a young patient population-12-year experience at Memorial Sloan Kettering Cancer Center

Journal of surgical oncology, 2009-07, Vol.100 (1), p.8-12

2009

Volltextzugriff (PDF)

Design, fabrication, and testing of a bistable electromagnetically actuated microvalve

Journal of microelectromechanical systems, 2000-06, Vol.9 (2), p.181-189

2000

Volltextzugriff (PDF)

318 Effects of Radiologic Tumor Response of Anti-Glypican-3 GC33 and Multi Tyrosine Kinases Inhibitor Sorafenib in Hepatocellular Carcinoma

European journal of cancer (1990), 2012-11, Vol.48, p.97-97

2012

Volltextzugriff (PDF)

Risk for contralateral breast cancer among carriers of the CHEK21100delC mutation in the WECARE Study

British journal of cancer, 2008-02, Vol.98 (4), p.728-733

2008

Volltextzugriff (PDF)

418P Concordance of PI3K-AKT pathway alterations between tumor and ctDNA in metastatic breast cancer

Annals of oncology, 2024-09, Vol.35, p.S395-S396

2024

Volltextzugriff (PDF)

1504MO Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum

Annals of oncology, 2024-09, Vol.35, p.S922-S922

2024

Volltextzugriff (PDF)

Abstract No. 168: Yttrium 90 resin microspheres as a salvage treatment for colon cancer liver metastases progressing after at least two prior lines of systemic chemotherapy: preliminary results

Journal of vascular and interventional radiology, 2012-03, Vol.23 (3), p.S70-S70

2012

Volltextzugriff (PDF)

Abstract No. 166: Phase I trial of yttrium 90 resin microspheres in the treatment of colon cancer liver metastases progressing despite hepatic arterial as well as systemic chemotherapy: preliminary results

Journal of vascular and interventional radiology, 2012-03, Vol.23 (3), p.S69-S70

2012

Volltextzugriff (PDF)

Systemic chemotherapy does not increase the risk of gastrointestinal perforation

Annals of oncology, 2007-12, Vol.18 (12), p.2006-2008

2007

Volltextzugriff (PDF)

P-266 Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)

Annals of oncology, 2023-06, Vol.34, p.S109-S109

2023

Volltextzugriff (PDF)

Phase II Trial Evaluating Esophageal Anastomotic Reinforcement with a Biologic, Degradable, Extracellular Matrix after Total Gastrectomy and Esophagectomy

Journal of the American College of Surgeons, 2022-05, Vol.234 (5), p.910-917

2022

Volltextzugriff (PDF)

1227P Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)

Annals of oncology, 2022-09, Vol.33, p.S1110

2022

Volltextzugriff (PDF)

1304P Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer

Annals of oncology, 2022-09, Vol.33, p.S1140

2022

Volltextzugriff (PDF)

Radiation Exposure, the ATM Gene, and Contralateral Breast Cancer in the Women's Environmental Cancer and Radiation Epidemiology Study

JNCI : Journal of the National Cancer Institute, 2010-04, Vol.102 (7), p.475-483

2010

Volltextzugriff (PDF)

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Annals of oncology, 2019-10, Vol.30, p.v313

2019

Volltextzugriff (PDF)

817P - First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Annals of oncology, 2019-10, Vol.30, p.v313-v313

2019

Volltextzugriff (PDF)

817PFirst-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(180)

Publikationsform

Artikel
(194)
Tagungsberichte
(3)

Sprache

Englisch
(197)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Clinical and molecular characterization of patients with cancer of unknown primary in the modern era

Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas

Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer

Tobacco Use Is Associated with Increased Recurrence and Death from Gastric Cancer

Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis

Risk factors for developing a new venous thromboembolism in ambulatory patients with non‐hematologic malignancies and impact on survival for gastroesophageal malignancies

A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma

Pancreatic adenocarcinoma in a young patient population-12-year experience at Memorial Sloan Kettering Cancer Center

Design, fabrication, and testing of a bistable electromagnetically actuated microvalve

318 Effects of Radiologic Tumor Response of Anti-Glypican-3 GC33 and Multi Tyrosine Kinases Inhibitor Sorafenib in Hepatocellular Carcinoma

Risk for contralateral breast cancer among carriers of the CHEK21100delC mutation in the WECARE Study

418P Concordance of PI3K-AKT pathway alterations between tumor and ctDNA in metastatic breast cancer

1504MO Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum

Abstract No. 168: Yttrium 90 resin microspheres as a salvage treatment for colon cancer liver metastases progressing after at least two prior lines of systemic chemotherapy: preliminary results

Abstract No. 166: Phase I trial of yttrium 90 resin microspheres in the treatment of colon cancer liver metastases progressing despite hepatic arterial as well as systemic chemotherapy: preliminary results

Systemic chemotherapy does not increase the risk of gastrointestinal perforation

P-266 Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)

Phase II Trial Evaluating Esophageal Anastomotic Reinforcement with a Biologic, Degradable, Extracellular Matrix after Total Gastrectomy and Esophagectomy

1227P Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)

1304P Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer

Radiation Exposure, the ATM Gene, and Contralateral Breast Cancer in the Women's Environmental Cancer and Radiation Epidemiology Study

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

817P - First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

817PFirst-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Suchergebnisse filtern